Ms Johane Boucher-Champagne, SFBC Anapharm’s Chief Operating Officer, is happy to announce the nomination of Ms Isabel Desmarais as Assistant Chief Operating Officer.
QUEBEC, May 6, 2005 -- Ms Johane Boucher-Champagne, SFBC Anapharm's Chief Operating Officer, is happy to announce the nomination of Ms Isabel Desmarais as Assistant Chief Operating Officer. Graduated in Pharmacy at the Universit Laval in 1995, Ms Desmarais also holds a Master in Hospital Pharmacy and a MBA in Business Management, completed in 2003 while working at SFBC Anapharm.
"Her expertise, her professionalism and her large contribution to SFBC Anapharm's business makes her the ideal candidate for this newly created job within our general management team. The dazzling expansion of our organization during the last years and the numerous challenges we have to face require excellence. I am therefore very happy to rely on such a quality person to help us in taking them up", declared Ms Boucher-Champagne
Since she joined SFBC Anapharm in 1998, Isabel Desmarais quickly got promotions within the company, being first a protocol writer, then a project manager and assistant director in our Scientific and Regulatory Affairs division. Having a strong 10-year experience in the pharmaceutical field, Isabel Desmarais has been acting as Project Management Director for 3 years at SFBC Anapharm, where she greatly contributed to the elaboration and development of many efficient and fast management programs and procedures for all critical aspects of studies and this, while respecting the highest quality standards.
Founded in Quebec in 1994, Anapharm, member of SFBC International, is the most important private contract research organisation specialized in phases I & II and bioequivalence tests in North America. The company offers leading services to pharmaceutical and biopharmaceutical companies all over the world. The company employs more than 700 specialists located in four sites in Quebec, its head office, in Montreal, Trois-Rivires and Toronto.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.